Structure based design of novel irreversible FAAH inhibitors.

Bioorg Med Chem Lett

Pfizer Global Research and Development, 700 Chesterfield PKWY West, Chesterfield, MO 63017, USA.

Published: October 2009

Fatty acid amide hydrolase (FAAH) has attracted significant attention due to its promise as an analgesic target. This has resulted in the discovery of numerous chemical classes as inhibitors of this potential therapeutic target. In this paper we disclose a new series of novel FAAH irreversible azetidine urea inhibitors. In general these compounds illustrate potent activity against the rat FAAH enzyme. Our SAR studies allowed us to optimize this series resulting in the identification of compounds 13 which were potent inhibitors of both human and rat enzyme. This series of compounds illustrated good hydrolase selectivity along with good PK properties.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2009.07.101DOI Listing

Publication Analysis

Top Keywords

structure based
4
based design
4
design novel
4
novel irreversible
4
faah
4
irreversible faah
4
inhibitors
4
faah inhibitors
4
inhibitors fatty
4
fatty acid
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!